|
0
|
|
Advances in Multiple Sclerosis.
(nejm.org)
|
Hauser SL
New England Journal of Medicine
2026-07-02
|
#neuroinflammation
#autoimmunity
#immunotherapy
#demyelination
#neurodegeneration
|
|
0
|
|
USP20 promotes CD8(+) T cell exhaustion and impairs KRAS(G12D) inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.
(gut.bmj.com)
|
Yu Z
…
Jiao Z
Gut
2026-07-02
|
#pancreatic cancer
#metabolism
#immunotherapy
#single-cell sequencing
#drug resistance
|
|
0
|
|
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
(nejm.org)
|
Choueiri TK
…
Powles TB
New England Journal of Medicine
2026-07-02
|
#clinical trial
#immunotherapy
#carcinoma
#adjuvant
#hif-inhibitor
|
|
0
|
|
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
(nejm.org)
|
Torkildsen O
…
Myhr KM
New England Journal of Medicine
2026-07-02
|
#multiple sclerosis
#antibody
#clinical trial
#immunotherapy
#autoimmunity
|
|
0
|
|
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer.
(linkinghub.elsevier.com)
|
Wright SJ
…
Park RJ
Cell Reports Medicine
2026-07-02
|
#immunotherapy
#t cell
#gastric cancer
#sequencing
#immunogenomics
|